Omnicell Inc (OMCL)
27.43
-1.00
(-3.52%)
USD |
NASDAQ |
Apr 24, 16:00
27.44
+0.01
(+0.04%)
After-Hours: 20:00
Omnicell Revenue (Quarterly): 258.85M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 258.85M |
| September 30, 2023 | 298.66M |
| June 30, 2023 | 298.97M |
| March 31, 2023 | 290.63M |
| December 31, 2022 | 297.67M |
| September 30, 2022 | 348.06M |
| June 30, 2022 | 331.39M |
| March 31, 2022 | 318.83M |
| December 31, 2021 | 311.03M |
| September 30, 2021 | 296.40M |
| June 30, 2021 | 272.74M |
| March 31, 2021 | 251.84M |
| December 31, 2020 | 249.20M |
| September 30, 2020 | 213.70M |
| June 30, 2020 | 199.62M |
| March 31, 2020 | 229.69M |
| December 31, 2019 | 248.29M |
| September 30, 2019 | 228.80M |
| June 30, 2019 | 217.41M |
| March 31, 2019 | 202.52M |
| December 31, 2018 | 211.75M |
| September 30, 2018 | 204.27M |
| June 30, 2018 | 188.67M |
| March 31, 2018 | 182.62M |
| December 31, 2017 | 196.37M |
| Date | Value |
|---|---|
| September 30, 2017 | 186.75M |
| June 30, 2017 | 181.04M |
| March 31, 2017 | 148.55M |
| December 31, 2016 | 175.26M |
| September 30, 2016 | 176.74M |
| June 30, 2016 | 172.91M |
| March 31, 2016 | 171.00M |
| December 31, 2015 | 130.32M |
| September 30, 2015 | 125.23M |
| June 30, 2015 | 112.79M |
| March 31, 2015 | 116.22M |
| December 31, 2014 | 121.54M |
| September 30, 2014 | 112.54M |
| June 30, 2014 | 105.05M |
| March 31, 2014 | 101.76M |
| December 31, 2013 | 105.75M |
| September 30, 2013 | 94.04M |
| June 30, 2013 | 93.69M |
| March 31, 2013 | 87.11M |
| December 31, 2012 | 90.17M |
| September 30, 2012 | 84.33M |
| June 30, 2012 | 75.38M |
| March 31, 2012 | 64.14M |
| December 31, 2011 | 62.93M |
| September 30, 2011 | 64.44M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
199.62M
Minimum
Jun 2020
348.06M
Maximum
Sep 2022
271.67M
Average
272.74M
Median
Jun 2021
Revenue (Quarterly) Benchmarks
| Teladoc Health Inc | 660.53M |
| American Shared Hospital Services | 5.698M |
| Novo Integrated Sciences Inc | 3.171M |
| Astrana Health Inc | 353.04M |
| Cryo-Cell International Inc | 7.852M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.38M |
| Total Expenses (Quarterly) | 282.21M |
| EPS Diluted (Quarterly) | -0.32 |
| Enterprise Value | 1.397B |
| Gross Profit Margin (Quarterly) | 40.72% |
| Profit Margin (Quarterly) | -5.55% |
| Earnings Yield | -1.64% |
| Normalized Earnings Yield | -1.640 |